药物设计的综合分子建模和机器学习
Song Xia1, Eric Chen1, Yingkai Zhang1,2,3
1Department of Chemistry, New York University, New York, New York 10003, United States.
Journal of chemical theory and computation
|October 26, 2023
概括
计算工具整合了分子建模和机器学习,以加速药物发现. 这些方法有助于设计调节器,预测分子性质,选潜在的候选药物,减少开发时间和成本.
科学领域:
- 计算化学是一种计算化学.
- 药物发现 药物发现
- 在药理学中的机器学习.
背景情况:
- 药物开发是一个漫长的,代的过程,需要大量的投资.
- 计算方法对于减少制药研发的时间和成本至关重要.
- 整合分子建模和机器学习为药物发现提供了强大的工具.
研究的目的:
- 为计算机药物设计提供整合分子建模和机器学习的视角.
- 突出针对蛋白质-蛋白质相互作用和选候选药物的新型计算工具.
- 为了展示这些工具的应用,使用FDA批准的药物的真实实例来展示这些工具的应用.
主要方法:
- 使用AlphaSpace用于蛋白质-蛋白质相互作用目标的口袋引导理性设计.
- 德尔塔机器学习评分功能用于蛋白质-连接体对接和虚拟选.
- 基于优化几何形状的深度学习模型来预测分子性质.
主要成果:
- 开发用于调制器设计的集成计算工具.
- 成功应用AlphaSpace以准蛋白质与蛋白质相互作用.
- 实施先进的机器学习和深度学习模型,用于财产预测和选.
结论:
- 综合计算方法显著提高了药物发现和开发的效率.
- 这些工具为未来的治疗设计提供了有希望的方向.
- 提出的方法是使用激酶抑制剂埃尔洛提尼布 (Erlotinib) 验证的,这是FDA批准的药物.
更多相关视频
10:21Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
2.6K
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
1.2K
相关概念视频
Structure-Activity Relationships and Drug Design
735
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
735
Drug Discovery: Overview
8.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.0K
Molecular Models
38.5K
Physical models representing molecular architectures of chemical compounds play essential roles in understanding chemistry. The use of molecular models makes it easier to visualize the structures and shapes of atoms and molecules.
38.5K
Ligand Binding Sites
12.9K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.9K
Quantitative Aspects of Drug-Receptor Interaction
1.0K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.0K
Protein-protein Interfaces
12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
